What Is BMI, and What Does It Tell You?

How BMI Is Calculated

BMI is a simple ratio of weight to the square of height. The math takes about ten seconds and requires no blood draw, imaging, or specialist equipment, which is exactly why Adolphe Quetelet derived it in the 1830s as a population statistics tool and why medicine adopted it as a clinical screen in the 20th century.

The Formula

For metric units: BMI = weight in kilograms divided by (height in meters)². A person who weighs 80 kg and stands 1.75 m tall has a BMI of 80 / (1.75 × 1.75) = 26.1 kg/m².

For imperial units: BMI = (weight in pounds × 703) divided by (height in inches)². The CDC provides a validated online calculator at cdc.gov that handles both unit systems [1].

Why the Square of Height?

Squaring height normalizes the weight-to-height relationship across body sizes. A taller person has more bone, organ, and muscle volume roughly proportional to height squared, not height alone. The adjustment is imperfect, which contributes to one of BMI's documented biases: taller individuals tend to carry slightly higher BMIs for equivalent adiposity compared with shorter individuals [2].

Children and Adolescents Use Percentiles, Not Fixed Cutoffs

Adult BMI cutoffs do not apply to anyone under age 20. Pediatric BMI is plotted on age- and sex-specific growth charts from the CDC, and a child is classified as overweight at the 85th to 94th percentile and obese at or above the 95th percentile for their age and sex [1]. Using adult thresholds in children produces substantial misclassification.

What the BMI Categories Mean Clinically

The four-category system used in the United States comes from a 1998 National Institutes of Health report that aligned American thresholds with World Health Organization classifications. Each band carries a different average risk profile for cardiometabolic disease, sleep apnea, type 2 diabetes, and all-cause mortality.

Underweight (BMI below 18.5)

A BMI <18.5 is associated with increased risk for nutritional deficiencies, bone loss, impaired immune function, and, in women, hypothalamic amenorrhea. A 2014 meta-analysis published in the Journal of Epidemiology and Community Health (N = 51,571 adults followed for up to 20 years) found that underweight adults had significantly higher all-cause mortality than those in the healthy-weight range [3]. Clinicians should rule out malabsorption, eating disorders, hyperthyroidism, and malignancy before attributing low BMI to constitutional thinness alone.

Healthy Weight (18.5 to 24.9)

This range is associated with the lowest average risk for most cardiometabolic outcomes in large epidemiological cohorts. The association is not absolute. A person with a BMI of 24 who smokes, has central adiposity, a fasting glucose of 110 mg/dL, and a sedentary lifestyle may carry more metabolic risk than the number suggests.

Overweight (25.0 to 29.9)

The overweight category is the most debated. A 2013 JAMA meta-analysis by Flegal et al. (N = 2.88 million participants across 97 cohort studies) found that overweight adults (BMI 25 to 29.9) had 6% lower all-cause mortality than normal-weight adults, a finding that generated significant scientific controversy about whether the BMI cutoff is placed correctly [4]. Visceral fat distribution within this BMI range drives risk more than the BMI number itself.

Obesity Classes I, II, and III

Class I (BMI 30 to 34.9), class II (35 to 39.9), and class III (40 and above) carry progressively higher risks for type 2 diabetes, hypertension, coronary artery disease, stroke, obstructive sleep apnea, certain cancers (including colorectal, breast post-menopause, and endometrial), and reduced life expectancy. The American Heart Association states in its 2021 scientific statement: "Obesity is a chronic, progressive, relapsing, and treatable multifactorial disease wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces resulting in adverse metabolic, biomechanical, and psychosocial health consequences." [5]

What BMI Actually Tells You (and What It Does Not)

BMI tells you where your weight-to-height ratio falls relative to a reference population. It does not directly measure body fat percentage, visceral fat volume, skeletal muscle mass, bone density, or metabolic health. Those distinctions matter enormously in clinical practice.

The Muscle Misclassification Problem

A 6-foot, 220-pound competitive sprinter with 10% body fat has a BMI of 29.9, placing them in the "overweight" category. A sedentary 6-foot adult at 220 pounds with 30% body fat has the identical BMI. Standard BMI measurement cannot tell those two people apart. Research using dual-energy X-ray absorptiometry (DEXA) scans, the gold standard for body composition, consistently shows that BMI misclassifies 20 to 35% of individuals when compared against measured fat mass [6].

Ethnic and Racial Differences in Adiposity at the Same BMI

South Asian, East Asian, and Southeast Asian adults accumulate visceral fat and develop metabolic complications at lower BMI values than European adults. The World Health Organization's expert consultation on Asian populations recommended lowering the overweight threshold to 23.0 and the obesity threshold to 27.5 for Asian populations [7]. The American Heart Association reinforced this in 2023 guidance recommending that clinicians use BMI 27.5 as the obesity action threshold for patients of Asian descent [5].

Black adults, on average, have higher lean muscle mass and bone mineral density at equivalent BMI compared with white adults, meaning BMI may overestimate adiposity-related risk in this group. Hispanic adults show variable patterns depending on country of origin. These differences mean that a single universal cutoff will always be more accurate for some groups than others.

The "Metabolically Healthy Obese" Debate

A subset of people with BMI above 30 show no insulin resistance, normal blood pressure, normal lipids, and normal inflammatory markers. Studies estimate this phenotype applies to 10 to 30% of individuals with obesity, depending on how "metabolically healthy" is defined and the age of the cohort. A 2020 study in Diabetologia (N = 381,363 UK Biobank participants) found that metabolically healthy obese individuals still had meaningfully higher risk for coronary heart disease and atrial fibrillation compared with metabolically healthy normal-weight controls, suggesting the "healthy obese" label does not mean risk-free [8]. BMI alone, without metabolic labs, misses this nuance entirely.

What Clinicians Use Alongside BMI

Because BMI is a surrogate, guidelines recommend pairing it with at least one direct measure of central adiposity and a metabolic lab panel.

Waist Circumference

Visceral (abdominal) fat is more metabolically active and more strongly linked to cardiovascular disease than subcutaneous fat. The National Heart, Lung, and Blood Institute sets elevated waist circumference thresholds at more than 40 inches (102 cm) for men and more than 35 inches (88 cm) for women. A person with a BMI of 27 and a waist of 41 inches (male) carries higher cardiometabolic risk than a person with a BMI of 31 and a waist of 36 inches.

Waist-to-Height Ratio

Waist-to-height ratio (WHtR) divides waist circumference by height, both in the same unit. A WHtR above 0.5 is associated with increased metabolic risk across most ethnic groups and may outperform both BMI and waist circumference alone for predicting cardiovascular events [9]. The practical rule: your waist should be less than half your height.

Body Composition Testing

DEXA scanning provides fat mass, lean mass, and bone density by body region. Bioelectrical impedance analysis (BIA) is cheaper and more accessible but less accurate, particularly in people who are dehydrated or have atypical fluid distribution. InBody and similar clinical BIA devices are accurate enough for tracking trends over time in most patients.

Metabolic Labs

Fasting glucose (normal <100 mg/dL), hemoglobin A1c, fasting insulin, triglycerides, HDL cholesterol, and blood pressure together form the metabolic syndrome criteria. The presence of three or more of the five metabolic syndrome components (per the National Cholesterol Education Program ATP III criteria) significantly elevates cardiovascular and diabetes risk regardless of BMI category.

BMI in the Context of Weight-Loss Treatment Decisions

BMI is not just a descriptive number. It is also a formal eligibility threshold for several medical and surgical interventions.

FDA-Approved GLP-1 Receptor Agonists

The FDA approved semaglutide 2.4 mg (Wegovy) in June 2021 for chronic weight management in adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (hypertension, type 2 diabetes, or dyslipidemia) [10]. In the STEP-1 trial (N = 1,961), semaglutide 2.4 mg produced a mean weight loss of 14.9% at 68 weeks versus 2.4% with placebo (P<0.001) [11]. Tirzepatide 2.5 to 15 mg (Zepbound), approved by the FDA in November 2023, uses the same BMI eligibility criteria and produced up to 20.9% mean weight loss in the SURMOUNT-1 trial (N = 2,539) at 72 weeks [12].

Bariatric Surgery Thresholds

The American Society for Metabolic and Bariatric Surgery and the American College of Surgeons set the standard surgical eligibility threshold at BMI 35 with a comorbidity or BMI 40 without one. Updated 2022 guidelines from the American Society for Metabolic and Bariatric Surgery extended eligibility to BMI 30 to 34.9 with metabolic disease, acknowledging that fixed BMI cutoffs were too blunt a tool for surgical decision-making [13].

Insurance and Prior Authorization

Most U.S. Commercial insurers and Medicare use BMI thresholds as gatekeeping criteria for approving anti-obesity medications and bariatric procedures. A patient who loses weight through lifestyle intervention and drops from BMI 31 to BMI 29 may lose coverage eligibility even if their metabolic risk remains elevated, illustrating one of the real-world consequences of relying on a single number.

Original HealthRX Clinical Framework: The BMI-Plus Assessment

Standard BMI alone leaves too much clinical information on the table. The HealthRX medical team uses a four-point BMI-Plus Assessment at intake to contextualize the BMI number before any treatment recommendation is made:

1. BMI category (standard WHO/CDC classification, with Asian-adjusted thresholds where applicable).
2. Waist-to-height ratio (flag if WHtR exceeds 0.5, regardless of BMI category).
3. Metabolic phenotype (assess fasting glucose, A1c, triglycerides, HDL, and blood pressure; classify as metabolically healthy or metabolically unhealthy by modified ATP III criteria).
4. Body composition context (ask about strength training history and consider BIA or DEXA if BMI and waist data conflict, such as a BMI of 29 with a waist of 32 inches in a patient who lifts weights five days per week).

A patient's treatment tier (lifestyle counseling alone, pharmacotherapy, or combined approach) is determined by the highest-risk signal across all four points, not by BMI alone. This approach aligns with the 2023 American Gastroenterological Association Clinical Practice Guideline on pharmacotherapy for adults with obesity, which states that treatment decisions should incorporate "weight-related complications and patient preferences" rather than BMI thresholds in isolation [14].

BMI Across the Lifespan

Older Adults

BMI operates differently in adults over age 65. Sarcopenic obesity, the combination of excess fat and low skeletal muscle mass, can produce a normal or mildly elevated BMI while the underlying body composition is adverse. The European Working Group on Sarcopenia in Older People (EWGSOP2) recommends assessing muscle strength (grip dynamometry) and muscle mass (DEXA or BIA) in older adults regardless of BMI [15]. A BMI below 22 in an adult over 70 is associated with higher mortality risk than in younger adults, which is why some geriatric guidelines use 22 to 27 as the preferred range for this age group.

Pregnancy

BMI before conception informs obstetric risk stratification. Pre-pregnancy obesity (BMI 30 or above) is associated with higher rates of gestational diabetes, pre-eclampsia, cesarean delivery, and fetal macrosomia. The American College of Obstetricians and Gynecologists (ACOG) recommends that clinicians discuss BMI and weight management as part of preconception counseling [16]. BMI during pregnancy is tracked differently, with gestational weight gain targets set by the Institute of Medicine based on pre-pregnancy BMI category rather than a single absolute threshold.

Adolescents and Young Adults

As noted earlier, pediatric BMI uses age- and sex-specific percentiles through age 19. The transition to adult cutoffs at age 20 can create apparent discontinuities in classification, particularly for adolescents near the 85th or 95th percentile who then fall below the adult overweight or obese cutoffs. Clinicians should use clinical judgment and track trends over time rather than relying solely on a single-point classification.

Practical Takeaways for Patients

Knowing your BMI is a reasonable starting point. It costs nothing, requires no appointment, and gives you a rough sense of where you sit relative to population risk data. The number becomes more useful when you add context.

Check your waist circumference with a flexible tape measure at the level of your navel, exhaling normally before measuring. If your waist is more than half your height in the same units, that is a signal worth discussing with a clinician regardless of your BMI.

Get a basic metabolic panel. Fasting glucose below 100 mg/dL, A1c below 5.7%, triglycerides below 150 mg/dL, and blood pressure below 120/80 mmHg together indicate low near-term metabolic risk even if your BMI is in the overweight range.

If you strength train regularly or are of South or East Asian descent, discuss with your clinician whether your BMI threshold should be interpreted differently.

For patients already in the obesity range (BMI 30 or above), the 2023 AGA guideline recommends pharmacotherapy alongside lifestyle intervention as a first-line option for most adults, not as a last resort after years of failed diet attempts [14].